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Abstract
Background: Since men with chronic kidney disease (CKD) progress faster than women, an accurate assessment of
CKD progression rates should be based on gender differences in age-related decline of glomerular filtration rate
(GFR) in healthy individuals.
Methods: A Chinese sample population from a stratified, multistage, and clustered CKD screening study was
classified into healthy, at-risk, and CKD groups. The gender differences in estimated GFR (eGFR) and age-related
eGFR decline were calculated for each group after controlling for blood pressure, fasting glucose levels, serum
lipids levels, education level, and smoking status. After referencing to the healthy group, gender-specific
multivariate-adjusted rates of decline in eGFR and differences in the rates of decline were calculated for both CKD
and at-risk groups.
Results: The healthy, at-risk, and CKD groups consisted of 4569, 7434, and 1573 people, respectively. In all the
3 groups, the multivariate-adjusted eGFRs in men were lower than the corresponding eGFRs in women. In
addition, in the healthy and at-risk groups, the rates of decline in eGFR in men were lower than the corresponding
rates of decline in women (healthy group: 0.51 mL·min
-1·1.73 m
-2·yr
-1 vs. 0.74 mL·min
-1·1.73 m
-2·yr
-1 and at-risk
group: 0.60 mL·min
-1·1.73 m
-2·yr
-1 vs. 0.73 mL·min
-1·1.73 m
-2·yr
-1). However, in the CKD group, the rates of decline in
eGFR in men were similar to those in women (0.96 mL·min
-1·1.73 m
-2·yr
-1 vs. 0.91 mL·min
-1·1.73 m
-2·yr
-1). However,
after referencing to the healthy group, the rates of decline in eGFR in men in the at-risk and CKD groups were
greater faster than the corresponding rates in women (at-risk group: 0.10 mL·min
-1·1.73 m
-2·yr
-1 vs. -0.03 mL·min
-
1·1.73 m
-2·yr
-1 and CKD group: 0.44 mL·min
-1·1.73 m
-2·yr
-1 vs. 0.15 mL·min
-1·1.73 m
-2·yr
-1).
Conclusion: To accurately assess gender differences in CKD progression rates, gender differences in age-related
decline in GFR should be considered.
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Background
Men with chronic kidney disease (CKD) progress to
end-stage CKD at a faster rate than women[1,2]. This
gender-specific difference cannot be fully explained on
the basis of differences in blood pressure, glucose meta-
bolism, or serum cholesterol levels. It is speculated that
this difference may be related to gender-specific differ-
ences in glomerular structure, hemodynamic condition,
activity of local cytokines and hormones, gene
expression, and/or the effects of sex hormones on kid-
ney cells[3,4]. However, these differences also exist in
healthy genders[5,6] and cause gender difference in age-
related loss of glomerular filtration rate (GFR) in healthy
population[7-9]. Thus, an accurate assessment of the
gender-specific CKD progression rate should be based
on the gender differences in age-related decline in GFR
in healthy individuals. In addition, some previous studies
did not observe a faster progression of CKD in men
[10,11]. The gender-specific difference in CKD progres-
sion rates reflect not only biological differences but also
differences in environmental, socioeconomic, lifestyle,
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as risk factors for CKD and its progression[12,13].
Therefore, to determine the effect of gender alone on
CKD progression, these factors should be adjusted.
Therefore, we used a randomly sampled population
from a well organized CKD screening study to deter-
mine gender-specific difference in CKD progression
rates after adjusting for the normal age-related GFR
decline and after controlling for potential confounding
variables, such as health status, socioeconomic status,
and lifestyle behaviors.
Methods
Participants and methods
We extracted a database of subjects from a stratified
CKD cluster sampling study performed in Beijing in
2006[14]. A total of 15,370 adults were selected from 53
primary sampling units and invited to participate.
Women needed to be oversampled to obtain sufficient
data due to the high male to female sex ratio in China.
After weighting, the ratio of men to women in the study
was 1:1.18. Ultimately, 13,925 subjects completed the
survey and physical examination. Overall, the enrollment
rate was 90.6% (92.1% of females and 89.6% of males).
The ethics committees in Peking university first hospital
approved this study. After obtaining informed consent
from all subjects, they completed a screening question-
naire to collect information about socioeconomic status
(e.g., gender, age, and education), personal and family
health history, and lifestyle behaviors (e.g., smoking).
Laboratory measurements also were made by well-
trained professionals using uniform standards.
Serum creatinine (Scr) was measured by using a
kinetic-rate method described by Jaffe. The glomerular
filtration rate was estimated by using a modified Modifi-
cation of Diet in Renal Disease (MDRD) Study formula
[15]: estimated GFR (eGFR, mL·min
-1·1.73 m
-2)=1 7 5×
standard (Scr)
-1.234 × age
-0.179 × 0.79 (if female).
Urine albumin and creatinine measurements were
made from morning spot urine samples. Urine albumin
was measured by using an immunoturbidimetric assay
(Audit Diagnostics, Cork, Ireland) and urine creatinine
was measured by using Jaffe’s kinetic method on a Hita-
chi 7170 chemistry analyzer (Tokyo, Japan). Albumi-
nuria was diagnosed if the urine albumin/creatinine
ratio was ≥17 mg·g
-1 for men or ≥25 mg·g
-1 for women
[16] and proteinuria was diagnosed if this ratio was
≥300 mg·g
-1 for either men or women.
Hypertension was defined as measurement of systolic
blood pressure ≥140 mmHg or diastolic blood pressure
≥ 90 mmHg, having been diagnosed with hypertension
at least twice, or taking an antihypertensive medication
at the time of the survey.
Diabetes was defined as measurement of a fasting glu-
cose level > 6.9 mmol·L
-1, a previous diagnosis of dia-
betes, or taking insulin or anti-diabetic medication at
the time of the survey.
Dyslipidemia was defined as measurement of total
cholesterol (TC) ≥6.22 mmol·L
-1, triglyceride (TG)
≥2.26 mmol·L
-1, high-density lipoprotein (HDL)
<1 . 0 4m m o l · L
-1, or low-density lipoprotein (LDL)
≥4.14 mmol·L
-1; a previous diagnosis of dyslipidemia; or
taking lipid-lowering medication at the time of the
survey.
Obesity was defined as having a body mass index
(BMI) ≥28 kg·m
-2 (BMI = weight/(height
2)).
Individuals whose eGFR was > 200 mL·min
-1·1.73 m
-2
(n = 33) or < 15 mL·min
-1·1.73 m
-2 (n = 57) were
excluded from this study. Participants were divided into
3 groups according to their health status: those with
albuminuria or eGFR < 60 mL·min
-1·1.73 m
-2 were placed
in the CKD group; those without CKD but with hyper-
tension, diabetes, dyslipidemia, or obesity were placed in
the at-risk group; those without CKD or other medical
conditions were placed in the healthy group. We also
used proteinuria as a definition of CKD and performed a
separate statistical analysis as described below because
currently there is no consensus about defining CKD by
microalbuminuria or macroalbuminuria. Some authors
only consider microalbuminuria to be a risk factor for
CKD such as (pre)hypertension or diabetes and its repro-
ducibility of microalbuminuria tests is limited [34].
Statistical analyses
General characteristics in each health status group
Sociodemographic characteristics (age, highest education
level), health indicators (BMI, fasting glucose level,
serum lipid levels, eGFR), and lifestyle behaviors (smok-
ing) of each gender were described by descriptive statis-
tics. The differences in these variables among genders
were examined by using chi-square statistics for catego-
rical variables and Student’s t-test for continuous values.
Gender-specific adjusted eGFRs in each health status group
For each health status group, a linear model was con-
structed with eGFR as the dependent variable, gender as
the independent variable, and confounding factors (sys-
tolic blood pressure, diastolic blood pressure, BMI, fast-
ing glucose level, serum lipid levels, highest education
level, and smoking) as covariates. This model was used
to calculate the least squares means of eGFR (adjusted
eGFR) and to compare eGFRs between genders within
each health status group.
Gender-specific rates of decline of eGFR in each health
status group
A linear model was constructed for each health status
group. In these models, the dependent variable was
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and interaction of age and gender. These models were
used to calculate the gender-specific rates of decline of
eGFR and to test gender-specific differences. Subse-
quently, confounding factors were added to these mod-
els as covariates to calculate the adjusted gender-specific
rates of decline of eGFR.
Adjusted gender-specific rates of decline of eGFR
(referenced to healthy group) in CKD and at-risk groups
A linear regression model was constructed for each gen-
der. In these models, the variables were (1) eGFR
(dependent variable); (2) age, health status, and interac-
tion of age and health status (independent variables);
and (3) the aforementioned confounding factors (covari-
ates). This model was used to calculate the adjusted
gender-specific rates of decline of eGFR (referenced to
the healthy group) for the CKD and at-risk groups. In
addition, a linear regression model was constructed with
the following variables: (1) eGFR (dependent variable);
(2) age, health status, gender, and interactions of age
and health status, age and gender, health status and gen-
der, age and health status and gender (independent vari-
ables); and (3) the aforementioned confounding factors
(covariates). This model was used to test for statistically
significant differences between men and women for the
adjusted gender-specific rates of decline of eGFR (refer-
enced to the healthy group) for the CKD and at-risk
groups.
All statistical analyses were performed using Statistical
Analysis System software, version 9.0 (SAS Institute
Inc., Cary, NC, USA). Tests for association were consid-
ered to be statistically significant when the p-values
were less than 0.05.
Results
The healthy, at-risk, and CKD groups consisted of 4569,
7434, and 1573 people, respectively. There were 1396
individuals (10.04%) with microalbuminuria, 104 (0.75%)
with proteinuria, and 261 (1.88%) with eGFR < 60
mL·min
-1·1.73 m
-2. In the healthy group, men had
higher BMIs, blood pressures, fasting glucose levels,
serum lipid levels, and lower education levels than
women of similar ages. In the at-risk group, men were
younger, had higher diastolic blood pressures, TG levels,
and education levels but lower levels of LDL, TC, and
HDL than women. In the CKD group, men had higher
blood pressures, TG levels, and education levels but
lower HDL levels than women. In each health status
group, men were more likely to be smokers. Compared
to individuals in the healthy group, those in the at-risk
and CKD groups were older and fatter and had higher
blood pressures and serum lipid levels. For men, the
prevalence of smoking was similar in all health status
groups and the CKD group had significantly lower
education levels than the healthy or at-risk groups. For
women, the at-risk and CKD groups had significantly
lower education levels and more smokers than the
healthy group (Table 1).
The gender differences of adjusted eGFRs in each
health status and age groups are shown in Table 2. In
the healthy group, men younger than 60 years old had
significantly lower eGFRs than women of similar ages.
After age 60, this relationship reversed but the differ-
ence was not significant. In the at-risk group, men
younger than 70 years old had significantly lower eGFRs
than women of similar ages. However, in the CKD
group, both men and women had similar eGFRs in each
age group.
As shown in Table 3, the unadjusted rates of decline of
eGFR were 0.51 mL·min
-1·1.73 m
-2·yr
-1 for men and
0.75 mL·min
-1·1.73 m
-2·yr
-1 for women in the healthy
group (p < 0.05), 0.53 mL·min
-1·1.73 m
-2·yr
-1 for men and
0.67 mL·min
-1·1.73 m
-2·yr
-1 for women in the at-risk
group (p < 0.05), and 0.89 mL·min
-1·1.73 m
-2·yr
-1 for men
and 0.88 mL·min
-1·1.73 m
-2·yr
-1 for women in the CKD
group (p > 0.05). After adjusting for covariates, the rates
of decline of eGFR were 0.51 mL·min
-1·1.73 m
-2·yr
-1 for
men and 0.74 mL·min
-1·1.73 m
-2·yr
-1 for women in the
healthy group (p < 0.05), 0.60 mL·min
-1·1.73 m
-2·yr
-1 for
men and 0.73 mL·min
-1·1.73 m
-2·yr
-1 for women in the
at-risk group (p < 0.05), and 0.96 mL·min
-1·1.73 m
-2·yr
-1
for men and 0.91 mL·min
-1·1.73 m
-2·yr
-1 for women in
the CKD group (p > 0.05). In addition, we calculated the
variation in the rates of decline of eGFR before and after
the age of 50. However, there was no significant differ-
ence for either gender in each health status group.
Table 3 also shows that the adjusted rates of decline
of eGFR (referenced to the healthy group) was
0.10 mL·min
-1·1.73 m
-2·yr
-1 (p < 0.05) for men and
-0.03 mL·min
-1·1.73 m
-2·yr
-1 (p > 0.05) for women in
the at-risk group and 0.44 mL·min
-1·1.73 m
-2·yr
-1
(p < 0.05) for men and 0.15 mL·min
-1·1.73 m
-2·yr
-1
(p < 0.05) for women in the CKD group. The gender
difference of the adjusted rate of decline of eGFR (refer-
enced to the healthy group) was statistically significant
for the CKD group (0.29 mL·min
-1·1.73 m
-2·yr
-1, p < 0.05)
but not the at-risk group (0.10 mL·min
-1·1.73 m
-2·yr
-1,
p>0 . 0 5 ) .
When we used proteinuria to define CKD, we
obtained different results for the CKD group (Table 4).
For men, the difference of the adjusted rate of decline
of eGFR between the CKD and healthy groups increased
from 0.44 mL·min
-1·1.73 m
-2·yr
-1 (p < 0.05) (Table 3) to
0.51 mL·min
-1·1.73 m
-2·yr
-1 (p < 0.05) (Table 4). For
women, this difference increased from 0.15 mL·min
-
1·1.73 m
-2·yr
-1 (p < 0.05) (Table 3) to 0.20 mL·min
-1·1.73
m
-2·yr
-1 (p < 0.05) (Table 4). However, the gender differ-
ence of the adjusted rate of decline of eGFR in the CKD
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mL·min
-1·1.73 m
-2·yr
-1 vs.0 . 3 1m L · m i n
-1·1.73 m
-2·yr
-1).
Moreover, these changes were quantitative but not qua-
litative, which was partly due to the significantly smaller
sample size in the CKD group when proteinuria was
used to define CKD.
Discussion
Currently information about gender differences in GFRs
in healthy individuals is limited and conflicting. For
example, our observation that men younger than
60 years old had lower eGFRs than women of similar
ages is both consistent[17] and inconsistent[7,18-21]
with previous studies. In addition, the information about
gender differences in age-related rates of decline of GFR
is not very consistent. For instance, our observation that
healthy men had lower rates of decline of eGFR than
healthy women is in agreement with some previous stu-
dies[8,22] but not others[7,21,23]. Unlike the partici-
pants in previous studies, who were voluntary kidney
donors[7,8,18,20,21,23] or local residents[17,19], partici-
pants in this study were selected from a prior stratified
cluster sampling study, which represented the study
population well and minimized selection bias.
Some earlier studies showed an increase in the rates of
decline of GFR in healthy individuals older than 40 or
50 years old[18,19,21] or a constant GFR for women
younger than 50 years old[23]. However, other studies
observed a linear relationship between GFR and age
[8,20]. In this study, we did not find any significant
difference in the rate of decline of eGFR before or after
the age of 50 for either gender. In addition, although we
observed that older healthy subjects had significantly
lower eGFRs than young healthy subjects, the difference
was not as large as we expected. This finding is consis-
tent with the hypothesis that kidney function may not
decrease with age but rather with age-related increases
in the incidence of degenerative diseases and risk factors
for vascular and kidney disease. In most former studies,
few study participants were elderly and exclusion criteria
were more relaxed than in our study. Any study about
the rate of decline of GFR in healthy individuals that
does not exclude all possible confounding factors that
can affect the GFR, which are common in the elderly,
would be expected to show an increased rate of decline
of GFR in the elderly.
Our observation that the rate of decline of eGFR in
men was slower in the healthy group but faster in the
CKD group could be explained by epidemiology studies.
In general, men have a higher incidence and prevalence
of end-stage renal disease (ESRD) than women [24,25];
however, most population-based CKD screening studies
show that men have a similar[14,26] or lower[27-29]
prevalence of CKD than women. This discrepancy sug-
gests 2 potential mechanisms for the rate of decline of
GFR between non-CKD and CKD stages. One possible
explanation is that renal function is preserved as healthy
individuals age at the expense of a gradual decrease in
the renal functional reserve[30]. Men may have a higher
renal functional reserve to compensate for the
Table 1 Characteristics of study participants in healthy, at-risk, and CKD groups
Healthy group At-risk group CKD group
male(n = 1311) female(n = 3258) male(n = 3338) female(n = 4096) male(n = 676) female(n = 897)
Age (years) 38.58 ± 13.23 38.00 ± 10.59 47.25 ± 13.14*# 50.54 ± 12.07& 51.62 ± 14.64# 50.92 ± 14.56&
BMI (kg·m
-2) 22.93 ± 2.54* 22.44 ± 2.56 26.05 ± 3.32# 26.12 ± 3.72& 26.30 ± 3.81# 25.98 ± 4.11&
FG (mmol·L
-1) 5.04 ± 0.45* 4.95 ± 0.43 5.72 ± 1.69# 5.79 ± 1.72& 6.28 ± 2.39# 6.09 ± 2.38&
HDL (mmol·L
-1) 1.36 ± 0.25* 1.48 ± 0.27 1.19 ± 0.30*# 1.34 ± 0.33& 1.24 ± 0.33*# 1.34 ± 0.31&
LDL (mmol·L
-1) 2.79 ± 0.69* 2.66 ± 0.64 3.29 ± 0.93*# 3.40 ± 0.94& 3.27 ± 1.03# 3.25 ± 0.97&
TC (mmol·L
-1) 4.41 ± 0.71* 4.37 ± 0.68 4.97 ± 0.99*# 5.11 ± 1.01& 5.02 ± 1.04# 5.05 ± 1.06&
TG (mmol·L
-1) 0.97 ± 0.44* 0.82 ± 0.37 1.93 ± 1.59*# 1.60 ± 1.20& 1.99 ± 1.78*# 1.65 ± 1.37&
DBP (mmHg) 76.07 ± 7.37* 72.83 ± 7.58 86.16 ± 10.98*# 84.27 ± 11.47& 88.75 ± 13.45*# 84.52 ± 12.93&
SBP (mmHg) 121.45 ± 9.24* 113.78 ± 10.97 137.23 ± 18.45# 136.92 ± 22.11& 144.51 ± 22.85*# 140.10 ± 26.68&
Low education (%) 34.23* 24.09 34.18* 46.67& 42.94*# 48.59&
Smoker (%) 56.29* 3.13 59.04* 5.74& 54.59* 7.15&
eGFR
(mL·min
-1·1.73 m
-2)
102.07 ± 19.23* 107.72 ± 20.60 94.74 ± 19.54*# 98.24 ± 19.89& 88.49 ± 25.98*# 92.32 ± 28.72&
adj-eGFR
(mL·min
-1·1.73 m
-2)
95.64 ± 0.60 * 102.08 ± 0.41 96.51 ± 0.34* 101.97 ± 0.34 92.28 ± 0.74*# 95.85 ± 0.67&
BMI: body mass index; FG: fasting glucose; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TC: total cholesterol; TG: triglyceride; DBP: diastolic blood
pressure; SBP: systolic blood pressure; eGFR: estimated glomerular filtration rate; adj-eGFR: eGFR adjusted for age, blood pressure, fasting glucose level, serum
lipid level, education level, and smoking
*: Compared to women in the same health status group, p < 0.05
#: Compared to men in the healthy group, p < 0.05
&: Compared to women in the healthy group, p < 0.05
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† (mL·min
-1·1.73 m
-2, mean ± standard error) in each age group in
healthy, at-risk, and CKD groups
Age group Healthy group At-risk group CKD group
Men Women Men Women Men Women
18-30 years Creatinine 83.94 ± 0.59* 64.41 ± 0.32 84.70 ± 0.66* 64.55 ± 0.70 86.72 ± 7.17* 66.61 ± 1.69
eGFR 109.13 ± 1.03* 118.89 ± 0.76 107.63 ± 1.27* 117.87 ± 1.63 111.38 ± 4.70 116.48 ± 3.30
adj-eGFR 107.83 ± 1.07* 119.56 ± 0.75 107.59 ± 1.22* 117.94 ± 1.81 108.39 ± 4.13 118.52 ± 3.34
N 384 729 328 162 47 69
30-40 years Creatinine 81.79 ± 0.63* 65.47 ± 0.28 84.76 ± 0.51* 66.29 ± 0.41 87.96 ± 1.57* 68.45 ± 1.41
eGFR 105.13 ± 1.04* 109.00 ± 0.57 100.89 ± 0.97* 107.14 ± 0.86 104.27 ± 2.41 106.62 ± 2.35
adj-eGFR 104.50 ± 1.08* 109.22 ± 0.58 101.42 ± 0.93* 106.62 ± 0.97 106.25 ± 2.73 105.11 ± 2.27
N 344 1077 556 514 90 126
40-50 years Creatinine 82.84 ± 0.61* 65.89 ± 0.30 84.82 ± 0.35* 66.45 ± 0.27 88.83 ± 1.97* 72.87 ± 1.50
eGFR 98.48 ± 0.94* 103.93 ± 0.61 95.82 ± 0.54* 102.65 ± 0.54 93.69 ± 1.64 96.38 ± 1.57
adj-eGFR 98.66 ± 1.09* 103.88 ± 0.58 96.13 ± 0.58* 102.42 ± 0.52 94.85 ± 1.83 95.56 ± 1.52
N 310 1026 1053 1308 175 248
50-60 years Creatinine 84.13 ± 0.79* 68.20 ± 0.51 86.19 ± 0.39* 68.85 ± 0.28 92.02 ± 1.91* 76.72 ± 2.06
eGFR 93.47 ± 1.15* 96.31 ± 0.95 90.91 ± 0.57* 94.94 ± 0.49 87.49 ± 1.74 90.32 ± 1.86
adj-eGFR 93.26 ± 1.29* 96.42 ± 0.92 90.89 ± 0.60* 94.95 ± 0.49 88.21 ± 1.92 89.71 ± 0.75
N 184 340 845 1212 170 204
60-70 years Creatinine 83.57 ± 1.37* 70.74 ± 1.28 87.53 ± 0.61* 70.14 ± 0.41 101.27 ± 3.22* 85.45 ± 4.76
eGFR 91.14 ± 1.87 88.76 ± 2.08 86.13 ± 0.78* 89.83 ± 0.70 76.30 ± 2.26 80.74 ± 2.45
adj-eGFR 91.20 ± 2.02 88.70 ± 2.08 86.03 ± 0.88* 89.76 ± 0.67 75.54 ± 2.43 81.63 ± 2.19
N 62 59 351 580 100 125
70-years Creatinine 84.92 ± 2.42* 72.16 ± 1.77 88.77 ± 0.79* 72.72 ± 0.55 109.46 ± 2.99* 86.89 ± 1.95
eGFR 87.46 ± 3.11 84.33 ± 2.66 82.48 ± 0.95 83.75 ± 0.85 67.07 ± 1.94 71.39 ± 2.14
adj-eGFR 90.17 ± 3.10 81.62 ± 3.10 82.69 ± 1.06 83.50 ± 0.84 65.82 ± 2.30 71.83 ± 1.97
N 27 27 205 320 94 125
†: Controlled for age, blood pressure, fasting glucose level, serum lipid level, education level, and smoking frequency
*: Compared to women in the same health status group, p < 0.05
Table 3 Differences in rates of decline in eGFR (mL·min
-1·1.73 m
-2·yr
-1, mean ± standard error) between genders and
between groups
Health group (n = 4569) Risk group (n = 7434) CKD group (n = 1573)
Male
(n = 1311)
Female
(n = 3258)
Male
(n = 3338)
Female
(n = 4096)
Male
(n = 676)
Female
(n = 897)
Unadjusted rates of decline in eGFR 0.51 ± 0.04* 0.75 ± 0.03 0.53 ± 0.02* 0.67 ± 0.02 0.89 ± 0.06 0.88 ± 0.06
Covariate-adjusted rates of decline in eGFR
† 0.52 ± 0.04* 0.75 ± 0.04 0.62 ± 0.03* 0.71 ± 0.03 0.94 ± 0.06 0.90 ± 0.08
Covariate-adjusted rates of decline in eGFR
†
(referenced to healthy group)
- - 0.10 ± 0.05& -0.03 ± 0.04 0.44 ± 0.06& 0.15 ± 0.06&
Gender difference in covariate-adjusted rates
of decline in eGFR
† (referenced to healthy
group)
- 0.10 ± 0.06 0.29 ± 0.09#
*: Compared to women in the same health status group, p < 0.05
&: Compared to healthy group in the same gender, p < 0.05
#: p < 0.05
†: Controlled for age, blood pressure, fasting glucose level, serum lipid level, education level, and smoking frequency
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Indeed, previous studies show that healthy men have a
greater ability to maintain their GFRs by increasing the
filtration fraction than women[31]. In addition, gender-
specific differences in glomerular hemodynamic may
contribute to differences in age-related decline of GFRs.
Another possible explanation is that although the
whole-body levels[6] and renal levels[32] of nitric oxide,
a vasodilator, are higher in healthy premenstrual women
than healthy men, which may cause a higher GFR in
premenstrual women, the renal vasculature of men may
become increasingly dependent on nitric oxide with age
compared with that of women[5]. If this is true, then
any renal disease that interferes with nitric oxide pro-
duction may cause kidney damage to progress more
quickly in men than in women.
This study had 3 potential limitations. First, the use of
estimated GFR to assess renal function in healthy indivi-
duals could be prone to measurement bias[17]. However,
when we used the Cockcroft-Gault formula, which was
developed from healthy individuals and is more accurate
than the MDRD formula[17], to assess renal function in
healthy individuals, men still had lower eGFRs and slower
age-related rates of decline of eGFR than women. Further-
more, when we excluded individuals younger than 30
years old (who are healthier), our results were similar. Sec-
ond, we had to estimate GFRs rather than measure them
directly and only a single measurement of serum creati-
nine was available for each participant. In addition, morn-
ing spot urine samples were collected rather than first
morning void urine samples. It is known that first morning
void urine samples may provide more accurate results of
albuminuria [33] and that the reproducibility of microal-
buminuria tests is limited (60-70%) [34]. Despite these
limitations, the procedures used in this study were chosen
due to the expense and inherent difficulties of directly
measuring GFRs and collecting first-morning void urine
samples and many blood and urine samples in a study
with more than 10,000 participants. Third, estimating age-
related rates of decline of eGFR from a cross-sectional
study undoubtedly produced bias; however, appropriate
mathematical models were used to reduce the bias as
much as possible. In addition, since men had a higher risk
of cardiovascular disease and death with increasing age,
especially those with chronic renal insufficiency, the
regression line of GFR against age would deviate from its
actual trend for a higher non-response rate in men than in
women. However, in this study, men had a similar
response rate as that in women (89.6% vs. 92.1%). More-
over, if a correction were made for the higher non-
response rate in unhealthy men, who tended to have lower
GFRs than participants who responded, then the gender
differences in the rate of decline of eGFR would be greater.
Conclusion
There are gender differences in the decline in GFR and
among different health statuses. To accurately evaluate
the gender differences in CKD progression rate, the
baseline gender differences in age-related decline in
GFR in healthy individuals should be considered.
Acknowledgements
We thank the Institute of Nephrology, Peking University First Hospital and
Beijing Centers for Diseases Control and Prevention (CDC) & Centers for
Preventive Medical Research for providing the data reported in this study.
Author details
1Institute of Nephrology, Peking University First Hospital, Beijing, China.
2Beijing Centers for Diseases Control and Prevention (CDC) & Centers for
Preventive Medical Research, Beijing, China.
Authors’ contributions
RX analyzed data and wrote the paper.
LXZ, PHZ, and FW performed research.
LZ and HYW designed research.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 20 March 2010 Accepted: 23 August 2010
Published: 23 August 2010
References
1. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression
of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000,
11:319-29.
Table 4 Differences in rates of decline in eGFR (mL·min
-1·1.73 m
-2·yr
-1, mean ± standard error) within genders and
between groups when proteinuria was used to define CKD
Health group (n = 4660) Risk group (n = 8566) CKD group (n = 341)
Male
(n = 1353)
Female
(n = 3307)
Male
(n = 3836)
Female
(n = 4730)
Male
(n = 130)
Female
(n = 211)
Unadjusted rates of decline in eGFR 0.52 ± 0.04* 0.75 ± 0.03 0.52 ± 0.02* 0.67 ± 0.02 0.97 ± 0.08 0.91 ± 0.07
Covariate-adjusted rates of decline in eGFR
† 0.52 ± 0.04* 0.74 ± 0.04 0.61 ± 0.03* 0.71 ± 0.03 1.03 ± 0.08 0.97 ± 0.10
Covariate-adjusted rates of decline in eGFR
†
(referenced to healthy group)
- - 0.10 ± 0.04& -0.03 ± 0.04 0.51 ± 0.08& 0.20 ± 0.07&
Gender difference of covariate adjusted rates
of decline in eGFR
† (referenced to healthy
group)
- 0.09 ± 0.06 0.31 ± 0.10#
Xu et al. BMC Nephrology 2010, 11:20
http://www.biomedcentral.com/1471-2369/11/20
Page 6 of 72. Silbiger SR, Neugarten J: The impact of gender on the progression of
chronic renal disease. Am J Kidney Dis 1995, 25:515-33.
3. Silbiger SR, Neugarten J: The role of gender in the progression of renal
disease. Adv Ren Replace Ther 2003, 10:3-14.
4. Lu H, Klaassen C: Gender differences in mRNA expression of ATP-binding
cassette efflux and bile acid transporters in kidney, liver, and intestine
of 5/6 nephrectomized rats. Drug Metab Dispos 2008, 36:16-23.
5. Sofia BAhmed, Naomi DLFisher, Norman K: Hollenberg. Gender and the
Renal Nitric Oxide Synthase System in Healthy Humans. Clin J Am Soc
Nephrol 2007, 916-931.
6. Forte P, Kneale BJ, Milne E, et al: Evidence for a difference in nitric oxide
biosynthesis between healthy women and men. Hypertension 1998,
32:730-4.
7. Barai S, Bandopadhayaya GP, Patel CD, et al: Do healthy potential kidney
donors in india have an average glomerular filtration rate of 81.4 ml/
min? Nephron Physiol 2005, 101:21-6.
8. Rule AD, Gussak HM, Pond GR, et al: Measured and estimated GFR in
healthy potential kidney donors. Am J Kidney Dis 2004, 43:112-9.
9. Fliser D, Zeier M, Nowack R, et al: Renal functional reserve in healthy
elderly subjects. J Am Soc Nephrol 1993, 3:1371-7.
10. D’Amico G: Influence of clinical and histological features on actuarial
renal survival in adult patients with idiopathic IgA nephropathy,
membranous nephropathy, and membranoproliferative
glomerulonephritis: survey of the recent literature. Am J Kidney Dis 1992,
20:315-23.
11. Coggins CH, Breyer Lewis J, Caggiula AW, et al: Differences between
women and men with chronic renal disease. Nephrol Dial Transplant 1998,
13:1430-7.
12. Orth SR, Hallan SI: Smoking: a risk factor for progression of chronic
kidney disease and for cardiovascular morbidity and mortality in renal
patients–absence of evidence or evidence of absence? Clin J Am Soc
Nephrol 2008, 3:226-36.
13. Taal MW, Brenner BM: Predicting initiation and progression of chronic
kidney disease: Developing renal risk scores. Kidney Int 2006, 70:1694-705.
14. Zhang L, Zhang P, Wang F, et al: Prevalence and factors associated with
CKD: a population study from Beijing. Am J Kidney Dis 2008, 51:373-84.
15. Ma YC, Zuo L, Chen JH, et al: Modified glomerular filtration rate
estimating equation for Chinese patients with chronic kidney disease. J
Am Soc Nephrol 2006, 17:2937-44.
16. Mattix HJ, Hsu CY, Shaykevich S, et al: Use of the albumin/creatinine ratio
to detect microalbuminuria: implications of sex and race. JA mS o c
Nephrol 2002, 13:1034-9.
17. Vervoort G, Willems HL, Wetzels JF: Assessment of glomerular filtration
rate in healthy subjects and normoalbuminuric diabetic patients: validity
of a new (MDRD) prediction equation. Nephrol Dial Transplant 2002,
17:1909-13.
18. Grewal GS, Blake GM: Reference data for 51Cr-EDTA measurements of the
glomerular filtration rate derived from live kidney donors. Nucl Med
Commun 2005, 26:61-5.
19. Klingensmith WC, Briggs DE, Smith WI: Technetium-99 m-MAG3 renal
studies: normal range and reproducibility of physiologic parameters as a
function of age and sex. J Nucl Med 1994, 35:1612-7.
20. Slack TK, Wilson DM: Normal renal function: CIN and CPAH in healthy
donors before and after nephrectomy. Mayo Clin Proc 1976, 51:296-300.
21. Granerus G, Aurell M: Reference values for 51Cr-EDTA clearance as a
measure of glomerular filtration rate. Scand J Clin Lab Invest 1981,
41:611-6.
22. Shyh-Dye Lee, Rong-Bin Chuang, Chia-Ming Li, Wen-Han Pan: Aging of
Renal Function Estimation in Elderly Community Dwellers Experiences in
Taiwanese Population. Tai J Geront S Med 2006, 1:159-172.
23. Berg UB: Differences in decline in GFR with age between males and
females. Reference data on clearances of inulin and PAH in potential
kidney donors. Nephrol Dial Transplant 2006, 21:2577-82.
24. Iseki K, Nakai S, Shinzato T, et al: Increasing gender difference in the
incidence of chronic dialysis therapy in Japan. Ther Apher Dial 2005,
9:407-11.
25. USRDS: USRDS 2007 Annual Data Report. National Institutes of Health,
National Institute of Diabetes and Digestive and Kidney Diseases. 2007,
84.
26. Coresh J, Astor BC, Greene T, et al: Prevalence of chronic kidney disease
and decreased kidney function in the adult US population: Third
National Health and Nutrition Examination Survey. Am J Kidney Dis 2003,
41:1-12.
27. Chadban SJ, Briganti EM, Kerr PG, et al: Prevalence of kidney damage in
Australian adults: The AusDiab kidney study. J Am Soc Nephrol 2003, 14:
S131-8.
28. Nitsch D, Felber Dietrich D, von Eckardstein A, et al: Prevalence of renal
impairment and its association with cardiovascular risk factors in a
general population: results of the Swiss SAPALDIA study. Nephrol Dial
Transplant 2006, 21:935-44.
29. Viktorsdottir O, Palsson R, Andresdottir MB, et al: Prevalence of chronic
kidney disease based on estimated glomerular filtration rate and
proteinuria in Icelandic adults. Nephrol Dial Transplant 2005, 20:1799-807.
30. Fuiano G, Sund S, Mazza G, et al: Renal hemodynamic response to
maximal vasodilating stimulus in healthy older subjects. Kidney Int 2001,
59:1052-8.
31. Miller JA, Anacta LA, Cattran DC: Impact of gender on the renal response
to angiotensin II. Kidney Int 1999, 55:278-85.
32. Reckelhoff JF, Hennington BS, Moore AG, et al: Gender differences in the
renal nitric oxide (NO) system: dissociation between expression of
endothelial NO synthase and renal hemodynamic response to NO
synthase inhibition. Am J Hypertens 1998, 11:97-104.
33. Witte EC, Lambers HHJ, de Zeeuw D, et al: First morning voids are more
reliable than spot urine samples to assess microalbuminuria. J Am Soc
Nephrol 2009, 20:436-43.
34. Coresh J, Astor BC, Greene T, et al: Prevalence of chronic kidney disease
and decreased kidney function in the adult US population: Third
National Health and Nutrition Examination Survey. Am J Kidney Dis 2003,
41:1-12.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2369/11/20/prepub
doi:10.1186/1471-2369-11-20
Cite this article as: Xu et al.: Gender differences in age-related decline
in glomerular filtration rates in healthy people and chronic kidney
disease patients. BMC Nephrology 2010 11:20.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Xu et al. BMC Nephrology 2010, 11:20
http://www.biomedcentral.com/1471-2369/11/20
Page 7 of 7